DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Hauser SL, Bar-Or A, Comi G. , et al; OPERA I and OPERA II Clinical Investigators.
Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis.
N Engl J Med 2017;
376 (03) 221-234
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.